Archive for the ‘biotech/medical’ category: Page 2471
Oct 18, 2016
Scientists May Have Reactivated The Gene That Causes Neurons To Stop Growing
Posted by Shane Hinshaw in categories: biotech/medical, neuroscience
In Brief:
- Scientists have found a way of reactivating genes in mice to continue neuron growth.
- The development could be key to helping patients with paralysis and neurodegenerative diseases.
Oct 18, 2016
I Got a $600 Brain ‘Reboot’ and It Changed My World
Posted by Shane Hinshaw in categories: biotech/medical, health, neuroscience
NAD+ therapy can supposedly increase your energy, focus, and metabolism, improve your cardiovascular health, and help you detox from alcohol and drugs. All this, of course, sounds incredibly unlikely—so I thought I’d see for myself.
Oct 18, 2016
Medical Innovations
Posted by Shailesh Prasad in categories: biotech/medical, innovation
Oct 17, 2016
A paralyzed man used his mind-controlled robotic hand to shake hands with President Obama at a Pittsburgh tech event
Posted by Shailesh Prasad in categories: biotech/medical, robotics/AI
Oct 17, 2016
Engineers reveal fabrication process for revolutionary transparent graphene neural sensors
Posted by Roman Mednitzer in categories: bioengineering, biotech/medical, genetics, neuroscience
In an open-access paper published Thursday (Oct. 13, 2016) in the journal Nature Protocols, University of Wisconsin–Madison engineers have published details of how to fabricate and use neural microelectrocorticography (μECoG) arrays made with transparent graphene in applications in electrophysiology, fluorescent microscopy, optical coherence tomography, and optogenetics.
Graphene is one of the most promising candidates for transparent neural electrodes, because the material has a UV to IR transparency of more than 90%, in addition to its high electrical and thermal conductivity, flexibility, and biocompatibility, the researchers note in the paper. That allows for simultaneous high-resolution imaging and optogenetic control.
Oct 17, 2016
Scientists create live animals from artificial eggs in ‘remarkable’ breakthrough
Posted by Shane Hinshaw in categories: biotech/medical, innovation
Artificial eggs have been grown in a petri dish for the first time and used to create living animals in a breakthrough hailed as ‘remarkable’ by British experts.
Scientists in Japan proved it is possible to take tissue cells from the tail of a mouse, reprogramme them as stem cells and then turn them into eggs in the lab.
The ‘eggs in a dish’ were then fertilised and the resulting embryos were implanted in female mice which went on to give birth to 11 healthy pups.
A group of scientists has taken the first important steps towards creating the Human Cell Atlas—a complete inventory of our staggeringly diverse cells.
Oct 16, 2016
Augmented Reality In Healthcare Will Be Revolutionary
Posted by Elmar Arunov in categories: augmented reality, biotech/medical
Augmented reality is one of the most promising digital technologies at present – look at the success of Pokémon Go – and it has the potential to change healthcare and everyday medicine completely for physicians and patients alike.
Oct 16, 2016
Zymergen – Synthetic Organisms Built by Robots and AI
Posted by Karen Hurst in categories: bioengineering, biotech/medical, robotics/AI
When you read about what some startups are doing these days it seems like you’re reading a sci-fi book. Earlier this year we published an article titled “3 Companies Building Nanorobot Companies” and we talked about using software, robots, and synthetic biology to engineer synthetic organisms (essentially nanorobots) that can be used to create efficiencies. According to BCC Research, the global market for microbes and microbial products was projected to approach $154.7 billion in 2015 and almost double to $306 billion by 2020. Healthcare is largest consumer of microbes (61%) followed by energy (24%) and manufacturing (13%). The massive size of the microbe industry is just begging for a bit of disruptive technology to address it and that’s exactly what Zymergen is getting up to.
Founded in 2013, San Francisco startup Zymergen has taken in a total of $174 million from a whole slew of investors that include Draper Fisher Jurvetson and Softbank. Their most recent funding round of $130 million closed just last week and was led by Softbank, a publicly traded Japanese technology conglomerate. This should come as no surprise considering Softbank has recently announced their intention to become the world’s number one technology investor with up to $100 billion allocated to investing in future technology companies.